A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT02595762 · COMPLETED
Trial details
- NCT number
- NCT02595762
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-10-30
- Primary completion
- 2023-11-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.